845 related articles for article (PubMed ID: 6491292)
1. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
Wright SC; Bonavida B
J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
4. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
[TBL] [Abstract][Full Text] [Related]
5. Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells.
Wayner EA; Brooks CG
J Immunol; 1984 Apr; 132(4):2135-42. PubMed ID: 6230401
[TBL] [Abstract][Full Text] [Related]
6. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
Graves SS; Bramhall J; Bonavida B
J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
Bonavida B; Katz J; Gottlieb M
J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
Wright SC; Bonavida B
J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
[TBL] [Abstract][Full Text] [Related]
10. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification.
Roozemond RC; Mevissen M; Urli DC; Bonavida B
J Immunol; 1987 Sep; 139(5):1739-46. PubMed ID: 3624869
[TBL] [Abstract][Full Text] [Related]
11. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
Farram E; Targan SR
J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
[TBL] [Abstract][Full Text] [Related]
12. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors.
Wright SC; Wilbur SM; Bonavida B
Nat Immun Cell Growth Regul; 1985; 4(4):202-20. PubMed ID: 2999581
[TBL] [Abstract][Full Text] [Related]
14. Rat natural killer cell and cytotoxic T cell lysis of H-2-negative murine embryonal carcinoma cells.
Bell SM; Stern PL
Eur J Immunol; 1985 Jan; 15(1):59-65. PubMed ID: 3155686
[TBL] [Abstract][Full Text] [Related]
15. Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells.
Blanca I; Herberman RB; Ortaldo JR
Nat Immun Cell Growth Regul; 1985; 4(1):48-59. PubMed ID: 4033671
[TBL] [Abstract][Full Text] [Related]
16. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
Roozemond RC; van der Geer P; Bonavida B
J Immunol; 1986 May; 136(10):3921-9. PubMed ID: 3701064
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
Wright SC; Bonavida B
J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
[No Abstract] [Full Text] [Related]
18. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
Hiserodt JC; Britvan L; Targan SR
J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of glucocorticoid action on murine natural killer cell activity.
Cox WI; Holbrook NJ; Friedman H
J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
